Medical Pharmaceuticals The most-up-to-date pharmaceutical news stories, including medical, cosmetic, and supplemental treatments. This section contains releases covering all aspects of the pharmaceutical sector, from research, development, and testing, through to product launches and marketing. Topics include clinical trials and studies, as well as updates on the FDA approval process for new treatment options. Learn about upcoming events, conferences, and educational initiatives. Also included is financial and corporate information from the sector, such as board decisions, appointments and changes, industry awards, and quarterly reports.

Latest

14:12 ET Wolf Administration Officials, Overdose Survivor Commend Pennsylvania EMS Providers for Using Narcan to Save Lives

Physician General Dr. Rachel Levine and Acting Secretary of Drug and Alcohol Programs Jennifer Smith commended South Central EMS today for their...


13:45 ET Dry Eye Drugs Price Analysis and Strategies 2012-2021: Identify How Drugs are Clinically and Commercially Positioned - Research and Markets

Research and Markets has announced the addition of the "Dry eye Drugs Price Analysis and Strategies - 2016" report to their offering. The latest...


12:59 ET First Systematic Study of Deadly, Antibiotic-Resistant Fungus Reported

The deadly fungus, Candida auris, which has been found in hospitals, is resistant to entire classes of antimicrobial drugs, limiting treatment...


12:44 ET Kaiser Permanente Names Jim Simpson President of Kaiser Foundation Health Plan of Georgia

Kaiser Permanente announced today that Jim Simpson has been named president of Kaiser Foundation Health Plan of Georgia. Simpson brings two...


12:15 ET Global $330.5 Billion Wireless Health Market Analysis & Trends 2013-2017 - Industry Forecast to 2025 - Research and Markets

Research and Markets has announced the addition of the "Global Wireless Health Market Analysis & Trends - Industry Forecast to 2025" report to...


12:00 ET Hemophilia Drugs Price Analysis and Strategies 2012-2016 & 2016-2021: How the Price Advanced from 2012 and Forecasts to 2021 - Research-and-Markets

Research and Markets has announced the addition of the "Hemophilia Drugs Price Analysis and Strategies - 2016" report to their offering. The...


11:45 ET Global $2.9 Billion Empty Capsules Market Analysis & Trends 2013-2017 & Industry Forecast to 2025: Increasing Demand for Empty Capsules in Nutraceutical Industry - Research and Markets

Research and Markets has announced the addition of the "Global Empty Capsules Market Analysis & Trends - Industry Forecast to 2025" report to...


11:16 ET In Children's Heart Disease: Decreasing Wound Infection Rates, Measuring Outcomes, Refining Clinical Tools

For the twentieth year, pediatric cardiology researchers and clinicians from multiple centers worldwide are sharing their findings at a large...


11:03 ET National Organization for Rare Disorders Awards New Research Grants for Rare Disease Research

The National Organization for Rare Disorders (NORD), the leading independent, nonprofit organization committed to the identification, treatment,...


11:00 ET Migraine Drugs Price Analysis and Strategies 2016-2021: Find out how the Price Advanced From 2012 and Forecast to 2021 - Research and Markets

Research and Markets has announced the addition of the "Migraine Drugs Price Analysis and Strategies - 2016" report to their offering. The...


10:56 ET Evidence review supports pediatric use of PDE-5 inhibitors for pulmonary hypertension

A systematic review of the comparative effectiveness and safety of phosphodiesterase type 5 (PDE-5) inhibitors in pediatric patients with pulmonary...


10:16 ET Hi-Tech Pharmaceuticals Sets the Record Straight on DMAA

Jared Wheat, CEO of Hi-Tech Pharmaceuticals, released the following statement in response to the FDA raid on Blackstone Labs this month: There...


10:00 ET Symic Bio Announces Last Patient Enrolled in SHIELD Trial of SB-030 for Interventions in Peripheral Artery Disease

Symic Bio, a biopharmaceutical company focused on matrix biology that is developing a new category of therapeutics, announced today the completion...


09:25 ET Aethlon Medical CEO Note: Bill Gates on the Threat of Bioterrorism

Aethlon Medical, Inc. (Nasdaq: AEMD), today released the following note authored by its Chairman and CEO, Jim Joyce. In a chilling address at the...


09:00 ET PhRMA Convenes Stakeholders to Discuss Value Assessments and New Ways to Pay for Medicines

Leaders across the health care continuum gathered yesterday in Washington, D.C., to discuss ways to improve payment and delivery systems in the...


09:00 ET E-QURE's BST Device for Chronic Wound Care Receives Marketing Approval in Israel

- Following receiving CE Marking in Europe, Israel's AMAR is a major milestone for the country where the device was developed -...


08:45 ET Developments in the Legal Cannabis Industry

A report published by The Hemp Business Journal estimates that the Cannabidiol (CBD) market will grow to a $2.1 billion market in consumer sales...


08:45 ET Cannabis Market Benefits from Legalization and Job Creation

The cannabis industry is expanding rapidly as support for cannabis legalization continues to rise in the United States. According to Arcview...


08:33 ET Provectus Biopharmaceuticals Provides Information On Rights Offering Deadline

Provectus Biopharmaceuticals, Inc. (OTCQB: PVCT, www.provectusbio.com) ("Provectus" or the "Company"), a clinical-stage oncology and dermatology...


08:30 ET ANI Pharmaceuticals Acquires Inderal® XL and InnoPran XL®

ANI Pharmaceuticals, Inc. ("ANI") (Nasdaq: ANIP) today announced that it has acquired Inderal® XL from Cranford Pharmaceuticals, LLC and InnoPran...


08:00 ET Targeting Chemokine Signaling to Overcome Radiation Resistance in Colorectal Cancer

An article published in Experimental Biology and Medicine (Volume 242, Issue 4, February, 2017) identifies a new pathway that renders colon cancers...


08:00 ET Real-World Data from Boehringer Ingelheim Show Lower Risk of Stroke and Major Bleeding for Pradaxa® (dabigatran etexilate mesylate) Compared to Warfarin

Boehringer Ingelheim Pharmaceuticals, Inc. today announced results from a real-world analysis showing that Pradaxa® (dabigatran etexilate mesylate)...


07:56 ET "Sound Bites" Event to Raise Funds for Tuberous Sclerosis Alliance

On Wednesday, March 1, the Tuberous Sclerosis Alliance (TS Alliance) will present Sound Bites, An Evening of Food, Wine and Music at the National...


07:20 ET Healthcare Stocks on Investors' Radar -- Alkermes, Teleflex, Cascadian Therapeutics, and InspireMD

This morning, Stock-Callers.com tracks the current performances of Alkermes PLC (NASDAQ: ALKS), Teleflex Inc. (NYSE: TFX), Cascadian Therapeutics...


07:20 ET Journal of Emergency Medical Services (JEMS) Partners with Asian Association for Emergency Medical Services (AAEMS)

PennWell Corporation, a diversified global media and conferences and exhibitions company, announced today a collaborative partnership between the...